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The positive findings on examination included the classical features of Parkinson's disease and a postural drop in blood pressure. The latter quickly resolved on withdrawal of his diuretic therapy. Two days after admission he started vomiting, initially four times on one day and then intermittently over the following 10 days. This usually occurred in the mornings. He was not receiving any new medication.
Fibreoptic gastroscopy showed multiple erosions in the lower part of his stomach and first part of the duodenum. His oesophagus appeared normal. Histology confirmed an active atrophic gastritis with many helicobacter-like organisms present. A full blooI count, biochemical screen and liver function tests were all normal. It transpired that every morning he washed himself on the ward with Hydrex. However, he also used this preparation as a mouth wash and then swallowed it. He said that he felt nauseated each time he did this.
He was advised to discontinue this practice and was given ranitidine. He made a full recovery with no further vomiting and repeat endoscopy after 6 weeks revealed resolution of his mucosal erosions with some mild residual antral gastritis.
Chlorhexidine is a bisbiguanide disinfectant which is effective against a wide range ofvegetative Gram-positive and Gram-negative bacteria. It is most active at a neutral or slightly acidic pH. Hydrex is a 4% solution of chlorhexidine gluconate in detergent that is used in pre-operative skin preparation and hand washing. There has been one report of an acute hepatitis and liver necrosis following ingestion of chlorhexidine gluconate in a suicide attempt.3 Because it is irritant, it is recommended that it should not be used on the brain, meninges, eyes, middle ear or other sensitive tissues.
There have been no previous reports of chlorhexidineinduced gastritis. This is presumably because the taste and consistency of concentrated preparations of chlorhexidine render them sufficiently unpalatable to discourage ingestion in the majority of cases. We have informed the manufacturers of Hydrex of our unusual observation in the hope that a recurrence of this problem can be avoided by providing a more visible written warning on the container. Her renal biochemistry was within normal limits and her only medication was tranylcypromine. Streptokinase infusion (I mega-unit over 1 hour) was commenced on the coronary care unit but was accompanied by severe hypotension (40 mmHg systolic) after 10 minutes, followed by a grand mal convulsion. Thrombolytic therapy was discontinued immediately and dobutamine infused, initially at a dose of 20 jig/kg/min. Despite inotropic support the patient remained significantly hypotensive for 2 hours although the cardiac rhythm remained unchanged.
Acute oliguric renal failure developed over the following 48 hours and this necessitated a period of peritoneal dialysis treatment. Renal recovery was delayed and she was subsequently transferred to our unit for further management. Investigations, including a radio-labelled renal 1st circulation study, were compatible with a diagnosis of acute tubular necrosis, and there was also evidence of underlying narrowing of the left renal artery. The patient is now well but she still has moderate impairment of renal function.
Allergic side effects of streptokinase are well recognized and may include hypotension and a serumsickness type reaction which has been observed in association with transient impairment of renal function.2 Although significant hypotension (systolic blood pressure < 80 mmHg) is observed in approximately 10% of patients with acute myocardial infarction who receive streptokinase at standard infusion rate (1.5 million IU/h),3 the effect is usually short-lived (< 10 minutes) and inotropic support rarely required.4 However, hypotension which is refractory to catecholamines may complicate the administration of streptokinase to patients with severe left ventricular dysfunction, and it has been recommended that such haemodynamically unstable subjects should receive the infusion at a much slower rate (200 IU/kg/min) -this perhaps should also be the case when treating some elderly patients. As similar hypotensive effects may complicate therapy with other thrombolytic agents, it is unlikely that a specific action of streptokinase is aetiologically important. 4 We have shown that significant renovascular narrowing is a common finding in middle-aged and elderly patients who have evidence of generalized atheroma. Such renal artery pathology may be associated with hypertension or may remain clinically occult, particularly in elderly patients.5 These should be identified as the patients most likely to have kidneys that will be vulnerable to ischaemic damage if systemic hypotension supervenes. Efforts to minimize renal hypoperfusion in such patients are necessary if acute renal failure is to be avoided, and a slower rate of streptokinase infusion may need to be considered in the at-risk (especially elderly) population requiring coronary thrombolysis.
